Mobile Dengue Diagnostic Technology (m-DDT):A smartphone-based point-of-care diagnostics and early warning system for epidemic prediction, preparedness and control.
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Hand-held device for diagnosis, prognosis and differentiation of vector-borne disease, dengue.
研究概览
简要总结
In this work, we intend to develop a portable, hand-heldmedical diagnostic device that will be capable of diagnosis and prognosis ofthe vector-borne disease dengue with genotypic specificity. On realizing theinitial prototype we intend to extend the device’s capability as amulti-analyte sensing platform to evaluate the presence of alternatevector-borne diseases such as: Malaria, Zika and Chikungunya. The novelty ofthis device is the determination of major vector-borne disease infection statusin real time without the need for any high-end equipment or laboratoryprocedures.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 6.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •Age: 6 years to 80 years Disease State: The patient is diagnosed with Dengue if he/she comes in with fever combined with 2 of the following additional symptoms: Headache, Retro-orbital pain, Myalgia, arthralgia, Rash, hemorrhagic manifestations, Petechiae, Purpurae, Platelets <1,00,000, Joint Pains, Hematocrit count >20% from Baseline.
排除标准
- •Patients with previous (past 3 months) blood transfusion and/or platelet transfusion are excluded from the study.
- •Patients below the age of 6 years and pregnant woman are excluded.
结局指标
主要结局
Hand-held device for diagnosis, prognosis and differentiation of vector-borne disease, dengue.
时间窗: First sample is collected at Febrile stage. Second sample is collected at Critical phase. Third sample is collected at recovery phase.
We intend to extend the device’s capability as a multi-analyte sensing platform to evaluate the presence of alternate vector-borne diseases.
时间窗: First sample is collected at Febrile stage. Second sample is collected at Critical phase. Third sample is collected at recovery phase.
次要结局
- We intend to extend the device’s capability as a multi-analyte sensing platform to evaluate the presence of alternate vector-borne diseases.(4 years)